Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Elliot B
EB
Tapper
D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D013501:Surface-Active Agents / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D013501:Surface-Active Agents; D011092:Polyethylene Glycols; D007792:Lactulose